MedPath

Evaluation of the effectiveness of systemic Echinacea on clinical indices of erosive oral lichen planus

Phase 2
Recruiting
Conditions
Erosive oral lichen planus.
Lichen planus
Registration Number
IRCT20200223046591N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
64
Inclusion Criteria

Patients sufering from erosive oral lichen planus refered to isfahan dental school department of oral medicine whose lesions are clinically and pathologically confirmed according to WHO criteria
Certaining of the patient's cooperation and consent
presence of at least one lichen planus lesion in oral cavity
according to modified Thongprasom criteria the clinical score must be more than 1

Exclusion Criteria

patients attended another clinical trial in past 3 months
pregnancy and lactation
presence of lichenoid reactions
presence of extraoral lesions
use of systemic steroid drugs, analgesics, immunomodulation drugs, NSAIDs a week before trial
presence of other lesions in oral cavity
history of asthma and allergy
patients suffering from systemic conditions such as diabetes, TB, high blood pressure, life threatening diseases and cancer
patients suffering from ulcerative colitis, entrogastric diseases, crohns syndrome, behjet`s syndrome, intensive anemia, rheumatoid arthritis, lupus, multiple sclerosis, collagen disorders, leukosis and AIDS
history of organ transplantation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
esion size. Timepoint: At baseline(before intervention),10,25 and 35 days after using Echinacea tablets. Method of measurement: graph paper and ruler.;Pain level. Timepoint: At baseline(before intervention),10,25 and 35 days after using Echinacea tablets. Method of measurement: Visual Analogue Scale index.
Secondary Outcome Measures
NameTimeMethod
Duration of lesion healing. Timepoint: At baseline(before intervention),10,25 and 35 days after using Echinacea tablets. Method of measurement: day.;Duration of pain relief. Timepoint: At baseline(before intervention),10,25 and 35 days after using Echinacea tablets. Method of measurement: day.
© Copyright 2025. All Rights Reserved by MedPath